Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series. | BMC Res Notes | 2022 | 36419139 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma. | Front Oncol | 2022 | 36408139 | PubTator, text mining | PubMed |
| Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma? | ESMO Open | 2022 | 36399952 | PubTator, text mining | PubMed |
| A refractory liver metastatic solid pseudopapillary neoplasm pancreas harbored CTNNB1 mutation showed good response to celecoxib: A case report. | Front Oncol | 2022 | 36387184 | PubTator, text mining | PubMed |
| Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors. | Front Pharmacol | 2022 | 36386148 | PubTator, text mining | PubMed |
| Mouse models of Kras activation in gastric cancer. | Exp Mol Med | 2022 | 36369466 | PubTator, text mining | PubMed |
| MAGE-A3 regulates tumor stemness in gastric cancer through the PI3K/AKT pathway. | Aging (Albany NY) | 2022 | 36367777 | PubTator, text mining | PubMed |
| Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways. | Cells | 2022 | 36359888 | PubTator, text mining | PubMed |
| Genetic Analyses of Cell-Free DNA in Pancreatic Juice or Bile for Diagnosing Pancreatic Duct and Biliary Tract Strictures. | Diagnostics (Basel) | 2022 | 36359547 | PubTator, text mining | PubMed |
| Molecular Analysis of Pancreatic Cyst Fluid for the Management of Intraductal Papillary Mucinous Neoplasms. | Diagnostics (Basel) | 2022 | 36359417 | PubTator, text mining | PubMed |
| Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors. | Cancers (Basel) | 2022 | 36358851 | PubTator, text mining | PubMed |
| Pathologies of Precursor Lesions of Biliary Tract Carcinoma. | Cancers (Basel) | 2022 | 36358777 | PubTator, text mining | PubMed |
| The E3 Ligases in Cervical Cancer and Endometrial Cancer. | Cancers (Basel) | 2022 | 36358773 | PubTator, text mining | PubMed |
| Molecular Analyses in Peritoneal Metastasis from Colorectal Cancer: A Review-An English Version. | J Anus Rectum Colon | 2022 | 36348949 | PubTator, text mining | PubMed |
| Directed evolution identifies high-affinity cystine-knot peptide agonists and antagonists of Wnt/β-catenin signaling. | Proc Natl Acad Sci U S A | 2022 | 36343233 | PubTator, text mining | PubMed |
| Ubiquitin modification in osteogenic differentiation and bone formation: From mechanisms to clinical significance. | Front Cell Dev Biol | 2022 | 36340031 | PubTator, text mining | PubMed |
| Systems biology and OMIC data integration to understand gastrointestinal cancers. | World J Clin Oncol | 2022 | 36337313 | PubTator, text mining | PubMed |
| Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma. | Sci Rep | 2022 | 36335135 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=28